| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/12/2008 | US20080139407 Segment synthesis |
| 06/12/2008 | US20080139405 Colloidal compositions for solid phase biomolecular analytical, preparative and identification systems |
| 06/12/2008 | US20080139401 Isolating biological modulators from biodiverse gene fragment libraries |
| 06/12/2008 | US20080139400 Molecular display on multimeric protein scaffolds |
| 06/12/2008 | US20080139397 Method Of Determining The Mutational Load Of A Gene Library Obtained By Random Mutagenesis Of A Particular Gene And Means For Implementing Same |
| 06/12/2008 | US20080138905 Method of Inducing Homologous Recombination |
| 06/12/2008 | US20080138904 Method Of Breeding Cells To Improve Tolerance To Short Chain Fatty Acids |
| 06/12/2008 | US20080138903 Regulating metabolism by modifying the level of trehalose-6-phosphate |
| 06/12/2008 | US20080138902 Transfecting with expression vector under control of murine cytomegalo virus promoter; glutamine synthetase and immunoglobulin gene |
| 06/12/2008 | US20080138901 Nucleotide having encapsidation signal and lacking overlapping sequences with nucleic acid of cell; safe large scale production; replication-defective |
| 06/12/2008 | US20080138894 Recombinant expression in eukaryotic or mammalian cells using vectors; cleavage and site-directed mutagenesis |
| 06/12/2008 | US20080138892 Rodent hepatitis viral nucleocapsids/core antigens for use as multivalent carrier platforms for enhancing the immune response to weak haptenic-like antigens |
| 06/12/2008 | US20080138877 Device which utilizes electrical pulse to make membranes porous to bioactive agents; drug delivery; gene therapy |
| 06/12/2008 | US20080138876 Transfection in electronically driven continuous flow |
| 06/12/2008 | US20080138874 Enhancing lipid formation in mortierella culture via suppression of fatty acid desaturase and elongase expression |
| 06/12/2008 | US20080138873 Yeast Strains With Improved Fructose Fermentation Capacity |
| 06/12/2008 | US20080138869 Novel supported catalyst systems |
| 06/12/2008 | US20080138863 Generating CDNA library comprising preferential sequences elements via replication and ligation of single standeded nucleic acids into vector with subsequent propagation in host |
| 06/12/2008 | US20080138861 Viral vector for use as efficient gene transfer and expression tool in genetic engineering |
| 06/12/2008 | US20080138859 Novel Promoter Nucleic Acid Derived From Corynebacterium Genus Bacteria, Expression Cassette Comprising The Promoter And Vector Comprising The Cassette, Host Cell Comprising The Vector And Method For Expressing A Gene Using The Cell |
| 06/12/2008 | US20080138858 Expression System for Recombinant Human Arginase I |
| 06/12/2008 | US20080138857 Using nutrient broth containing escherichia to translated preferential messenger RNA sequences |
| 06/12/2008 | US20080138851 Transgenic phaeodaclylurn for use as glucose transport model |
| 06/12/2008 | US20080138825 Methods and compositions for selectively cleaving DNA containing duplex nucleic acids in a complex nucleic acid mixture, and nuclease compositions for use in practicing the same |
| 06/12/2008 | US20080138823 Biochip for archiving and laboratory-medical analysis of biological smple material, process for its production, and its use in diagnostic methods |
| 06/12/2008 | US20080138820 Cell comprising reporter gene construct encoding fluorescent protein fused to centromere protein A, and second reporter gene construct encoding nitroreductase |
| 06/12/2008 | US20080138811 Tissue-Based Assay System for Alzheimer-Specific Degeneration and Pathology |
| 06/12/2008 | US20080138772 Instrument for Delivery of Optical Energy to the Dental Root Canal System for Hidden Bacterial and Live Biofilm Thermolysis |
| 06/12/2008 | US20080138365 Improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapy |
| 06/12/2008 | US20080138363 Attenuated Chimeric Flavivirus Bearing Attenuated Japanese Encephalitis Virus Gene as Backbone |
| 06/12/2008 | US20080138361 By virus-like proteins; transforming, culturing and isolating the recombinant yeast; immunotherapy of human papillomavirus-associated cancer |
| 06/12/2008 | US20080138358 Protective protein comprising protease sequences from newly excysted juveniles for use in vaccination and prevention of parasitic infection of gut tissues |
| 06/12/2008 | US20080138357 Vaccines Against Neisseria Meningitidis |
| 06/12/2008 | US20080138355 Modified leukotoxin gene and protein |
| 06/12/2008 | US20080138352 Identification and characterization of novel proline racemases and hydroxyproline-2-epimerases, uses thereof, and methods of identifying proline racemases and hydroxyproline-2-epimerases |
| 06/12/2008 | US20080138348 G-protein coupled receptor ligands and methods |
| 06/12/2008 | US20080138347 Dsp-10 dual-specificity phosphatase |
| 06/12/2008 | US20080138346 Antibodies to a chemokine expressed in inflamed adenoid |
| 06/12/2008 | US20080138345 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/12/2008 | US20080138344 Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same |
| 06/12/2008 | US20080138339 Anti human ovarian cancer-anti CD3 bispecific antibody |
| 06/12/2008 | US20080138336 Humanized Anti-CD19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease |
| 06/12/2008 | US20080138335 Stabilized Human IgG2 And IgG3 Antibodies |
| 06/12/2008 | US20080138331 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders |
| 06/12/2008 | US20080138325 Using microprojectiles comprising immobilized polynucleotide sequences as gene transfer agents |
| 06/12/2008 | US20080138318 Compositions Comprising Viruses and Methods for Concentrating Virus Preparations |
| 06/12/2008 | US20080138277 Drug delivery of therapeutic agent and carrier comprising targeting moiety that interacts with a target molecule such as chemokines, interferons, interleukins, osteoponting, chaperone proteins, receptors, and cellular adhesion molecules present in atherosclerotic lesions in blood vessels; diagnosis |
| 06/12/2008 | DE102006058373A1 (R)-Hydroxynitril-Lyase aus Brassicaceen (R) -hydroxynitrile lyase from Brassicaceae |
| 06/12/2008 | CA2674217A1 Regulation of plant metabolism |
| 06/12/2008 | CA2671656A1 Woody plants having improved growth characteristics and method for making the same |
| 06/12/2008 | CA2671633A1 Diagnostic agent for mesothelioma, diagnosis kit for mesothelioma, and diagnosis method for mesothelioma |
| 06/12/2008 | CA2671553A1 Ob-fold used as scaffold for engineering new specific binders |
| 06/12/2008 | CA2671524A1 Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration |
| 06/12/2008 | CA2671492A1 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 06/12/2008 | CA2671425A1 Method for modifying insect resistance of plants by utilizing rnai technique |
| 06/12/2008 | CA2671365A1 Novel selectable marker genes |
| 06/12/2008 | CA2671210A1 Method of determining the haplotype of multiple allelic genes |
| 06/12/2008 | CA2670933A1 Multi-channel electroporation system |
| 06/12/2008 | CA2670423A1 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same |
| 06/12/2008 | CA2669951A1 Protein particles |
| 06/12/2008 | CA2668942A1 Means and method for raising improved immune response |
| 06/12/2008 | CA2667574A1 Compositions and methods for binding sphingosine-1-phosphate |
| 06/12/2008 | CA2666383A1 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
| 06/12/2008 | CA2666057A1 Genetic variations associated with tumors |
| 06/12/2008 | CA2665371A1 Mn/ca9 splice variants |
| 06/12/2008 | CA2664219A1 Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity |
| 06/11/2008 | EP1930447A2 Methods and compositions for perioperative genomic profiling |
| 06/11/2008 | EP1930445A1 Kit and method for detection of urothelial cancer |
| 06/11/2008 | EP1930440A1 Bacterial Strains, Genes and Enzymes for Control of Bacterial Diseases by Quenching Quorum-Sensing Signals |
| 06/11/2008 | EP1930439A1 Neurotrophic factors |
| 06/11/2008 | EP1930438A1 Transcription factor for killer cell activation, differentiation and uses thereof |
| 06/11/2008 | EP1930437A1 Gankyrin |
| 06/11/2008 | EP1930436A1 Vector for delivering target substance into nucleus or cell |
| 06/11/2008 | EP1930435A1 Process for producing useful substance |
| 06/11/2008 | EP1930434A1 Protoporphyrinogen oxidase having activity of imparting resistance against acifluorfen and gene thereof |
| 06/11/2008 | EP1930433A1 T-cell receptor and nucleic acid encoding the receptor |
| 06/11/2008 | EP1930432A1 Tryptophan transporter gene and use thereof |
| 06/11/2008 | EP1930431A1 Gene capable of enhancing low temperature fermentation ability and/or freezing stress resistance and use thereof |
| 06/11/2008 | EP1930430A1 Method for specifically selecting antibody-producing cell |
| 06/11/2008 | EP1930429A1 Msx1/2, MARKERS OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON |
| 06/11/2008 | EP1930428A1 Yeast host, transformant and method of producing foreign protein |
| 06/11/2008 | EP1930426A1 Composition and method for diagnosing kidney cancer and estimating kidney cancer patient s prognosis |
| 06/11/2008 | EP1930425A1 Sequence capable of enhancing the expression of gene under moderately low temperature |
| 06/11/2008 | EP1930424A1 Novel apoptosis inducing factor and method of inducing apoptosis using the same |
| 06/11/2008 | EP1930423A1 Expression vector, transformant having the expression vector introduced therein, and process for production of heterologous protein |
| 06/11/2008 | EP1930422A1 Method for producing cdna and rna chains and nucleotide-immobilized support |
| 06/11/2008 | EP1930421A1 White hair development model animal, method for establishing white hair development model animal, method for passage of white hair development model animal, method for study on white hair development, screening method for white hair development-control means, and composition for control of white hair development |
| 06/11/2008 | EP1930420A1 Isolated nucleic acid molecules encoding a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 06/11/2008 | EP1930418A1 Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| 06/11/2008 | EP1930417A1 Bacteriophage composition useful in treating food products to prevent bacterial contamination |
| 06/11/2008 | EP1930416A1 Novel recombinant human hepatitis c virus-like particle and method for producing the same |
| 06/11/2008 | EP1930413A1 Technique for culture of mesenchymal stem cell utilizing laminin-5 |
| 06/11/2008 | EP1930410A1 L-glutamic acid-producing bacterium and method for production of l-glutamic acid |
| 06/11/2008 | EP1930409A1 L-glutamic acid-producing bacterium and method for production of l-glutamic acid |
| 06/11/2008 | EP1930406A1 Brain-migrating cell and use thereof |
| 06/11/2008 | EP1930344A1 Polypeptide having anti-angiogenic activity |
| 06/11/2008 | EP1930342A1 OB-fold used as scaffold for engineering new specific binders |
| 06/11/2008 | EP1930026A1 A method for generating birnavirus from synthetic RNA transcripts |
| 06/11/2008 | EP1930022A1 Treatment of bladder fibrosis with antibodies against alpha V beta 6 integrin |
| 06/11/2008 | EP1929860A1 Transgenic avian which has foreign gene containing sequence encoding feline-derived protein and method for production thereof |